Page 7 - Ea Scan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

An exhibit in France presents the artist's anatomic studies and shows how he anticipated the images produced by CT and MRI.

In a phase 3 trial, the monoclonal antibody donanemab slowed clinical and functional decline by 35% for patients with early Alzheimer's disease. However, the drug was not without safety issues.

Measuring the thickness of the retina shortly after diagnosis in multiple sclerosis patients could predict their risk of accumulated disability later in the disease course, say Austrian researchers.

New research criteria appear to accurately identify athletes in sports such as boxing or martial arts who will go on to develop chronic traumatic encephalopathy.

The Elecsys beta-amyloid (1-42) and Elecsys total-tau CSF assays (used as a tTau/Abeta42 ratio) are for use in adults ages 55 and older being evaluated for cognitive issues.